Pharmaceutical capsule compositions containing the active compound (2R)-2-[[(4-chlorophenyl)sulfonyl][[2-fluoro-4-(1,2,4-oxadiazol-3-yl)phenyl]methyl]amino]-5,5,5-trifluoropentanamide, and polyethylene glycol (PEG), Vitamin E polyethylene glycol succinate, polyvinylpyrrolidone (PVP) or copovidone (PVP-Polyvinyl acetate), with or without citric acid, are provided.본 발명은 활성 화합물 (2R)-2-[[(4-클로로페닐)술포닐][[2-플루오로-4-(1,2,4-옥사디아졸-3-일)페닐]메틸]아미노]-5,5,5-트리플루오로펜탄아미드, 및 폴리에틸렌 글리콜 (PEG), 비타민 E 폴리에틸렌 글리콜 숙시네이트, 폴리비닐피롤리돈 (PVP) 또는 코포비돈 (PVP-폴리비닐 아세테이트)을 함유하는 제약 캡슐 조성물 (시트르산 함유 또는 비함유)을 제공한다.